Trial
NCT01001598
Safety and Efficacy Trial of Danazol in Patients With Fanconi Anemia or Dyskeratosis Congenita
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Boston Children's Hospital
Collaborators
—
Condition
Fanconi Anemia
Intervention
danazol
Why stopped
Study was terminated due to under enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-02-19